Tube potential can be lowered to 80 kVp in test bolus phase of CT coronary angiography (CTCA) and CT pulmonary angiography (CTPA) to save dose without compromising diagnostic quality.

OBJECTIVES: The purpose of this study was to determine whether performing the test bolus (TB) of computed tomography coronary angiography (CTCA) and computed tomography pulmonary angiography (CTPA) at 80 kVp reduces dose without compromising diagnostic quality. METHODS: An 80 kVp TB protocol for CTCA and CTPA was retrospectively compared to standard TB protocol (non-obese: 100 kVp, obese: 120 kVp). CT angiogram parameters were unchanged between cohorts. Thirty-seven consecutive 80 kVp TB CTCA images were compared to 53 standard CTCA images. Fifty consecutive CTPAs from each protocol were analysed. Diagnostic quality of the CT angiogram was assessed by: mean attenuation, signal-to-noise ratio (SNR) in the ascending aorta (AA) in CTCA and in the main pulmonary artery (MPA) in CTPA, diagnostic rate, and number of repeated monitoring scans. Mean effective dose was estimated using the dose-length product. RESULTS: Mean TB effective doses were significantly lower (P < 0.0001) for 80 kVp scans compared to the standard in non-obese CTCA (0.15 ± 0.04 mSv Vs 0.33 ± 0.09 mSv), obese CTCA (0.17 ± 0.06 mSv Vs 0.57 ± 0.12 mSv), and CTPA patients (0.07 ± 0.03 mSv Vs 0.15 ± 0.06 mSv). No difference was demonstrated in mean attenuation, SNR (AA), SNR (MPA), diagnostic rates, or number of repeated monitoring scans between protocols. CONCLUSIONS: Routinely performing TB at 80 kVp, regardless of body habitus, in CTCA and CTPA results in a small but significant dose reduction, without compromising CT angiogram diagnostic quality. KEY POINTS: • CT coronary angiography is performed to exclude the presence of significant coronary atherosclerosis. • CT pulmonary angiography is performed to diagnose pulmonary thromboembolism. • This retrospective study showed dose reduction by performing test bolus at 80 kVp. • Diagnosis can be made with reduced exposure to ionising radiation.

A completed audit cycle of the lateral scan projection radiograph in CT pulmonary angiography (CTPA); the impact on scan length and radiation dose.

AIM: To investigate the effect of incorporating a lateral scan projection radiograph (topogram) in addition to the standard frontal topogram on excess scan length in computed tomography pulmonary angiography (CTPA) and to quantify the impact on effective dose. MATERIALS AND METHODS: Fifty consecutive patients referred for exclusion of pulmonary embolism who had undergone a CTPA examination with conventional frontal topogram to plan scan length (protocol A) were compared with 50 consecutive patients who had undergone a CTPA study with frontal and additional lateral topogram for planning (protocol B) in a retrospective audit. Optimal scan length was defined from lung apex to lung base. Mean excess scan length beyond these landmarks was determined. The mean organ doses to the thyroid, liver, and stomach, as well as mean effective dose, were estimated using standard conversion factors. RESULTS: The mean excess scan length was significantly lower in protocol B compared to the protocol A cohort (19.5 ± 17.4 mm [mean ± standard deviation] versus 39.1 ± 20.4 mm, p < 0.0001). The mean excess scan length below the lung bases was significantly lower in the protocol B cohort compared to the protocol A group (7.5 ± 12.7 mm versus 23 ± 16.6 mm, p < 0.0001), as were the mean organ doses to the stomach (4.24 ± 0.81 mGy versus 5.22 ± 1.06 mGy, p < 0.0001) and liver (5.60 ± 0.64 mGy versus 6.38 ± 0.81 mGy, p < 0.0001). A non-significant reduction in over-scanning above the apices in protocol B was observed compared with protocol A (12 ± 8.8 mm versus 16.2 ± 13.6 mm, p = 0.07), which equated to lower mean thyroid organ dose in (3.28 ± 1.76 mGy versus 4.11 ± 3.11 mGy, p = 0.104). CONCLUSION: The present audit indicates that incorporation of a lateral topogram into the CTPA protocol, together with radiographer education, reduces excess scan length, which significantly reduces the dose to the liver and stomach, and potentially lowers the dose to the thyroid. This simple dose-saving technique can be applied to all CT investigations of the chest on all CT systems with immediate effect.

Intravenous contrast medium administration at 128 multidetector row CT pulmonary angiography: bolus tracking versus test bolus and the implications for diagnostic quality and effective dose.

AIM: To investigate the effects of a test bolus protocol contrast medium administration on diagnostic image quality in computed tomography pulmonary angiography (CTPA). MATERIALS AND METHODS: Fifty patients referred for exclusion of pulmonary embolism underwent CTPA using a test bolus protocol CTPA at 120 kVp and were compared with 50 patients undergoing CTPA using a standard bolus-tracking protocol at 120 kVp, via assessment of attenuation, signal-to-noise ratio (SNR), and contrast-to-noise ratio (CNR) seen in the pulmonary arteries (PAs). An additional group of 10 non-obese patients who underwent CTPA using a test bolus protocol performed at 100 kVp were also analysed. Mean effective dose was calculated from the dose-length product, using standard conversion factors. RESULTS: The test bolus protocol showed significantly higher attenuation, SNR, and CNR in the pulmonary vasculature down to the segmental level compared to bolus-tracking CTPA (p < 0.0001). There was no significant difference in effective dose between the test bolus and bolus tracking cohorts. The additional group of test bolus CTPA examinations performed at 100 kVp had a significantly reduced effective dose in comparison to both test bolus CTPA at 120 kVp and bolus-tracking CTPA at 120 kVp (p < 0.005) yet maintained mean PA attenuation to segmental level significantly better than bolus-tracking CTPA performed at 120 kVp and comparable to the test bolus cohort performed at 120 kVp. CONCLUSION: Test bolus contrast administration should be used as an optimal protocol. Performing test bolus CTPA at 100 kVp, as opposed to 120 kVp, significantly reduces dose without compromising PA attenuation in non-obese subjects.

Neonatal chest and abdominal radiation dosimetry: a comparison of two radiographic techniques.

Radiographs of the chest and the abdomen are the most commonly requested diagnostic X-ray examinations undertaken in neonatal intensive care units. Frequently, for a single child, both radiographs are requested simultaneously. These images can be obtained either as two separate exposures (one of the chest and one of the abdomen), or as a single exposure to include both anatomical regions on one film. This study compared the effective dose imparted as a result of each technique. A neonatal anthropomorphic phantom was designed and constructed, and each radiographic technique was simulated. Entrance surface dose (ESD) and dose-area product (DAP) were measured and estimates of effective dose were made from the DAP values. The mean effective dose for the separate exposure technique was estimated to be 37.3 microSv compared with 35.5 microSv for the combined exposure technique. However, observed variations in field size gave rise to uncertainties in DAP and thus the effective doses estimated from it. Hence, no significant difference in effective dose was observed between the radiographic techniques. The observed coefficient of variation in field size (16% for a 2.5 kg neonate) demonstrates that good standards of radiographic practice are more important than choice of technique.

Practical patient dosimetry for partial rotation cone beam CT.

OBJECTIVES: This work investigates the validity of estimating effective dose for cone beam CT (CBCT) exposures from the weighted CT dose index (CTDIW) and irradiated length. METHODS: Measurements were made within cylindrical poly(methyl methacrylate) (PMMA) phantoms measuring 14 cm and 28 cm in length and 32 cm in diameter for the 200° DynaCT acquisition on the Siemens Artis zee fluoroscopy unit (Siemens Medical Solutions, Erlangen, Germany). An interpolated average dose was calculated to account for the partial rotation. Organ and effective doses were estimated by modelling projections in the Monte Carlo software programme PCXMC (STUK, Helsinki, Finland). RESULTS: The CTDIW was found to closely approximate the interpolated average dose if the positions of the measured doses reflected the X-ray beam rotation. The average dose was found to increase by 8% when the phantom length was increased from 14 to 28 cm. Using the interpolated average dose and the irradiated length for effective dose calculations gave similar values to PCXMC when a double-length (28-cm) CT dose index phantom was irradiated. Simplifying the estimation of effective dose with PCXMC by modelling just 4 projections around the abdomen gave effective doses that were only 7% different to those given when 41 projections were modelled. Calculated doses to key organs within the beam varied by as much as 27%. CONCLUSION: Estimating effective dose from the CTDIW and the irradiated length is sufficiently accurate for CBCT if the chamber positions are considered carefully. A conversion factor can be used only if a single CT dose index phantom is available. The estimation of organ doses requires a large number of modelled projections in PCXMC.

Fetal radiation dose from CT pulmonary angiography in late pregnancy: a phantom study.

Pulmonary embolism (PE) is the leading direct cause of maternal mortality in the UK. Accurate diagnosis is important but, even though CT pulmonary angiography (CTPA) is the recommended imaging modality for PE in the general population, there is limited guidance for pregnant patients. Knowledge of the radiation doses to both the mother and the fetus is therefore important in the justification of CTPA in this situation. Dose measurements were made on three helical CT scanners, with an anthropomorphic phantom representing the chest and abdomen in late gestation. Estimated fetal doses from CT scans of the maternal chest were in the range of 60-230 microGy. Fetal dose reduction strategies (mA modulation, shielding with a lead coat, and a 5 cm shorter scan length) were investigated. These reduced the fetal dose by 10%, 35% and 56%, respectively. Fetal doses from a scan projection radiograph (SPR) of the maternal chest were insignificant when compared with the dose from a CT scan. However, if the SPR was not stopped before the "fetus" was directly irradiated, the dose measured on one scanner was 20 microGy.